[ Price : $8.95]
FDA grants Daiichi Sankyo a breakthrough therapy designation for quizartinib, an investigational FLT3 inhibitor for treating adult...[ Price : $8.95]
FDA releases the FDA-483 with six observations from a Sharp Drugs inspection.[ Price : $8.95]
The New Civil Liberties Alliance asks FDA to adopt a rule that would require the agency to regulate only through notice-and-commen...[ Price : $8.95]
FDA commissioner Scott Gottlieb says the agency is working on a new CVM five-year plan to advance antimicrobial stewardship in vet...[ Price : $8.95]
FDA warns Japans Yuki Gosei Kogyo about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
Federal Register notice: FDA announces the fee rates and payment procedures for medical device user fees for fiscal year 2019.[ Price : $8.95]
Federal Register notice: FDA announces the rates for biosimilar user fees for fiscal year 2019.[ Price : $8.95]
Americans for Homeopathic Choice asks FDA to reconsider its petition that homeopathic drugs will be considered to be new drugs.